Veranova, a global developer and manufacturer of specialty and complex active pharmaceutical ingredients (APIs) for the pharma and biopharma sectors, has appointed Thomas Rohrer as Vice President of Bioconjugation. This appointment follows a recently announced investment to establish cGMP bioconjugation capabilities at its Devens, MA site. Thomas brings more than 40 years of experience and a comprehensive understanding of biological process development and clinical manufacturing, including 30...